Impact of extended-release dalfampridine on walking ability in patients with multiple sclerosis
about
4-Aminopyridine for symptomatic treatment of multiple sclerosis: a systematic reviewThe role of exercise in modifying outcomes for people with multiple sclerosis: a randomized trial.Abnormal NMDA receptor function exacerbates experimental autoimmune encephalomyelitisCritical Appraisal of Evidence for Improving Gait Speed in People with Multiple Sclerosis: Dalfampridine Versus Gait TrainingCross-cultural adaptation and validation of the 12-item Multiple Sclerosis Walking Scale (MSWS-12) for the Brazilian population.Experience with fampridine in clinical practice: analysis of a possible marker of clinical response.
P2860
Impact of extended-release dalfampridine on walking ability in patients with multiple sclerosis
description
2011 nî lūn-bûn
@nan
2011 թուականի Ապրիլին հրատարակուած գիտական յօդուած
@hyw
2011 թվականի ապրիլին հրատարակված գիտական հոդված
@hy
2011年の論文
@ja
2011年論文
@yue
2011年論文
@zh-hant
2011年論文
@zh-hk
2011年論文
@zh-mo
2011年論文
@zh-tw
2011年论文
@wuu
name
Impact of extended-release dal ...... tients with multiple sclerosis
@ast
Impact of extended-release dal ...... tients with multiple sclerosis
@en
Impact of extended-release dal ...... tients with multiple sclerosis
@nl
type
label
Impact of extended-release dal ...... tients with multiple sclerosis
@ast
Impact of extended-release dal ...... tients with multiple sclerosis
@en
Impact of extended-release dal ...... tients with multiple sclerosis
@nl
prefLabel
Impact of extended-release dal ...... tients with multiple sclerosis
@ast
Impact of extended-release dal ...... tients with multiple sclerosis
@en
Impact of extended-release dal ...... tients with multiple sclerosis
@nl
P2860
P356
P1476
Impact of extended-release dal ...... tients with multiple sclerosis
@en
P2093
Keith C Hayes
P2860
P304
P356
10.2147/NDT.S10469
P407
P577
2011-04-28T00:00:00Z